4th Quarter - Report
PODESTA GROUP, INC. for GENZYME
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Protection and Affordable Care Act (implementation). S. 957, Drug Supply Chain Security Act. S. 959, Pharmaceutical Quality, Security, and Accountability Act. FDASIA implementation.Sustainable Growth Rate repeal and reform proposals.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NORA CONNORS | — |
| STEPHEN NORTHRUP | — |
| ANTHONY PODESTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.